United Therapeutics reported $91M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amarin AMRN:US USD 227.61M 1.83M
Ardelyx ARDX:US USD 1.25M 3.28M
Baxter International BAX:US USD 2.68B 12M
Bayer BAYN:GR EUR 12.79B 1.42B
Biogen BIIB:US USD 1.38B 80.8M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Emergent Biosolutions EBS:US USD 546.3M 120.8M
Esperion Therapeutics ESPR:US USD 29.54M 313K
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Halozyme Therapeutics HALO:US USD 103.28M 5.66M
Insmed INSM:US USD 66.28M 741K
Intra Cellular Therapies ITCI:US USD 23.6M 1.42M
Moderna Inc MRNA:US USD 2.08B 156M
Ptc Therapeutics PTCT:US USD 14.81M 192K
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Sarepta Therapeutics SRPT:US USD 221.19M 13.1M
Seattle Genetics SGEN:US USD 364.97M 45.62M
Teva Pharmaceutical TEVA:IT USD 3.86B 190M
United Therapeutics UTHR:US USD 91M 1.1M
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M